Edition:
United Kingdom

IQVIA Holdings Inc (IQV.N)

IQV.N on New York Stock Exchange

105.08USD
4:56pm BST
Change (% chg)

$1.80 (+1.74%)
Prev Close
$103.28
Open
$104.00
Day's High
$105.45
Day's Low
$103.49
Volume
290,066
Avg. Vol
315,502
52-wk High
$110.66
52-wk Low
$87.10

Latest Key Developments (Source: Significant Developments)

IQVIA Announces Senior Secured Credit Facility Transaction to Refinance Existing Indebtedness
Monday, 11 Jun 2018 

June 11 (Reuters) - IQVIA Holdings Inc ::IQVIA ANNOUNCES SENIOR SECURED CREDIT FACILITY TRANSACTION TO REFINANCE EXISTING INDEBTEDNESS.IQVIA HOLDINGS INC - PLACED APPROXIMATELY $1.65 BILLION OF USD AND EUR TERM B LOANS.IQVIA HOLDINGS - PROCEEDS OF ADDITIONAL TERM B LOANS USED TO PAY DOWN REVOLVING CREDIT FACILITY, REFINANCE $650 MILLION OF EXISTING USD TERM B LOANS DUE 2024.  Full Article

IQVIA Reaffirms Its Second-Quarter and FY 2018 Guidance
Friday, 18 May 2018 

May 17 (Reuters) - IQVIA Holdings Inc ::SEES FY 2018 REVENUE GUIDANCE RANGE OF $10.05 BILLION TO $10.25 BILLION.IQVIA REAFFIRMS ITS SECOND-QUARTER AND FULL-YEAR 2018 GUIDANCE, INCLUDING ADJUSTED EPS GROWTH OF 13.6% TO 20.4% AND 14.3% TO 19.9%, RESPECTIVELY.REAFFIRMS FY 2018 ADJUSTED EARNINGS PER SHARE VIEW $5.20 TO $5.45.  Full Article

IQVIA Responds To FDA Statement Regarding Conversion Measurement Issue
Wednesday, 16 May 2018 

May 16 (Reuters) - IQVIA Holdings Inc ::IQVIA RESPONSE TO FDA STATEMENT.IQVIA HOLDINGS - RECENTLY MADE CORRECTION TO KILOGRAM CONVERSION MEASUREMENT IN UNITED STATES IQVIA NATIONAL SALES PERSPECTIVE MARKET RESEARCH SERVICE.IQVIA HOLDINGS INC - CORRECTION AFFECTS REPORTED MEASUREMENTS FOR TRANSDERMAL PATCHES IN OPIOID MARKET.IQVIA HOLDINGS INC - IQVIA'S INTERNAL PROCESSES HAD ALREADY IDENTIFIED MEASUREMENT CONVERSION ISSUE PRIOR TO FDA'S NOTIFICATION.IQVIA HOLDINGS INC - NOTIFIED CO'S CLIENTS ABOUT THE MEASUREMENT CONVERSION ISSUE IN APRIL OF THIS YEAR.IQVIA - MEASUREMENT CONVERSION ISSUE DOES NOT IMPACT WIDELY USED U.S. & GLOBAL DOLLAR & UNIT INFORMATION IN NATIONAL SALES PERSPECTIVE.IQVIA HOLDINGS INC - ONGOING STEPS HAVE BEEN UNDERTAKEN TO CORRECT THE MEASUREMENT CONVERSION ISSUE IN THIS OFFERING.IQVIA HOLDINGS INC - WILL CONTINUE WORKING WITH FDA TO RESOLVE THE CONCERNS.IQVIA - MEASUREMENT CONVERSION ISSUE DOES NOT IMPACT INFORMATION IN ANY OTHER IQVIA MARKET RESEARCH SERVICES, METHODOLOGIES OR OFFERINGS.  Full Article

Iqvia Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock
Tuesday, 15 May 2018 

May 15 (Reuters) - IQVIA Holdings Inc ::IQVIA ANNOUNCES LAUNCH OF SECONDARY PUBLIC OFFERING AND REPURCHASE OF COMMON STOCK.IQVIA HOLDINGS - LAUNCH UNDERWRITTEN, SECONDARY PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK BY CERTAIN OF ITS EXISTING STOCKHOLDERS.  Full Article

IQVIA Announces Pricing Of Secondary Public Offering
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - IQVIA Holdings Inc ::IQVIA ANNOUNCES PRICING OF SECONDARY PUBLIC OFFERING.IQVIA HOLDINGS INC - ‍PRICING OF UNDERWRITTEN, SECONDARY PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK BY CERTAIN OF ITS EXISTING STOCKHOLDERS​.IQVIA HOLDINGS INC - ‍IQVIA INTENDS TO REPURCHASE FROM UNDERWRITER 2.5 MILLION SHARES​.IQVIA HOLDINGS-REPURCHASE WILL BE COMPLETED OUTSIDE CO'S EXISTING SHARE REPURCHASE PROGRAM, UNDER WHICH CO HAS ABOUT $195 MILLION OF REMAINING AVAILABILITY​.  Full Article

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Iqvia Holdings Inc ::IQVIA ANNOUNCES LAUNCH OF SECONDARY PUBLIC OFFERING AND REPURCHASE OF COMMON STOCK.IQVIA HOLDINGS INC - ‍LAUNCH OF AN UNDERWRITTEN, SECONDARY PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK​.  Full Article

QuintilesIMS Holdings will be changing its name to IQVIA
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Quintiles Ims Holdings Inc ::Will be changing its name to IQVIA effective November 6, 2017​.Beginning Nov 15, equity shares of co will trade on NYSE under new name and new ticker symbol "IQV."​.  Full Article

QuintilesIMS says Q3 GAAP earnings per share $0.38
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Quintiles IMS Holdings Inc -:QuintilesIMS reports third-quarter 2017 results.Q3 adjusted earnings per share $1.19.Q3 GAAP earnings per share $0.38.Q3 revenue $2.019 billion versus I/B/E/S view $2.01 billion.Sees Q4 adjusted earnings per share $1.28 to $1.37.Sees Q4 revenue $2.12 billion to $2.16 billion.Q3 earnings per share view $1.14 -- Thomson Reuters I/B/E/S.Q4 earnings per share view $1.35, revenue view $2.13 billion -- Thomson Reuters I/B/E/S.  Full Article

Quintiles IMS announces offering of senior notes
Monday, 11 Sep 2017 

Sept 11 (Reuters) - Quintiles Ims Holdings Inc - :Quintiles IMS announces offering of senior notes, redemption of existing euro senior notes and proposed amendment to senior secured credit facility.Wholly owned unit intends to raise EUR 420 million in gross proceeds through an offering of senior notes due 2025.Quintiles IMS also announced that issuer intends to pursue an amendment to its senior secured credit facility.Terms of amendment are expected to provide for an incremental term loan B of up to $750 million.Quintiles IMS- announced that issuer delivered a conditional notice of redemption to its outstanding 4.125% euro-denominated senior notes due 2023.Quintiles IMS-proceeds from notes offering, together with proceeds from amendment, will be used to refinance certain indebtedness of issuer.  Full Article

Quintiles Q2 gaap earnings per share $0.712
Wednesday, 27 Jul 2016 

Quintiles Transnational Holdings Inc : Q2 earnings per share view $0.90 -- Thomson Reuters I/B/E/S . For three months ended june 30, 2016, company's service revenues were $1.17 billion which represents growth of 8.6% . Updating full year 2016 service revenue constant currency growth guidance to 6.0% to 7.0% . Is increasing its diluted adjusted eps guidance to $3.78 to $3.88 per share for fy . FY guidance assumes foreign currency exchange rates in effect at end of june remain in effect for remainder of year . Sees full year 2016 constant currency service revenue growth guidance to a range of between 6.0% and 7.0% compared to fy 2015 . Updating 2016 integrated healthcare services constant currency service revenue guidance to a 3.0% to 6.0% decline compared 2015 . FY2016 earnings per share view $3.78, revenue view $4.63 billion -- Thomson Reuters I/B/E/S .FY 2016 diluted gaap eps guidance of $3.26 to $3.41 per share.  Full Article

UPDATE 2-FDA reports inaccuracy in IQVIA data on opioids

May 16 The U.S. Food & Drug Administration on Wednesday said it found inaccuracies in information on opioid sales provided by healthcare data firm IQVIA Holdings Inc and called on the company to hire an independent auditor to review its data quality.